-
Mar. 2014
LEUKOCARE is pleased to announce the launch of its new website in March 2014
-
Dec. 2013
LEUKOCARE licenses its stabilizing and protecting technologies for veterinarian vaccine
-
Oct. 2013
Scil Proteins and LEUKOCARE develop a stabilized recombinant human thrombin manufactured in bacteria
-
Oct. 2013
Innovative Influenza A vaccine formulation increases stability and provides new options for production and storage
-
Oct. 2013
Xenios and LEUKOCARE announce strategic partnership in the field of anti-inflammatory coatings for next generation extracorporeal support systems
-
Sep. 2013
LEUKOCARE announces EUR 3.4 M capital increase
-
May. 2013
LEUKOCARE in collaboration with Technical University Munich (TUM) develops a novel HBV vaccine and receives grant by German government
-
Oct. 2012
2012LEUKOCARE licenses biomarker cell-free DNA to Trillium Diagnostics
-
Sep. 2012
LEUKOCARE to publish scientific findings and background of its SPS®-technology in Materials Today
-
Jul. 2012
LEUKOCARE provides key technologies for tumour diagnosis in personalized medicine research project